Epoch Biotech
PrivateLast Round
Grant
Aug 1, 2025
Total Funding Raised
$1.56M
Company Overview
Epoch Biotech is a biotechnology company developing patient-inspired therapeutics for Alzheimer's disease based on the APOE Christchurch variant.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epoch Biotech Comparables
Compare Epoch Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Muna Therapeutics | 78% | |
| Gismo Therapeutics | 78% | |
| Artery Therapeutics, Inc. | 76% |
Epoch Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 1, 2025 | ||||
| Seed | Jun 25, 2025 | ||||
| Seed | Jul 17, 2024 | ||||
| Seed | Jul 11, 2023 |
Epoch Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2025
$499K grant received from the National Institute on Aging.
- Jul 17, 2024
$40K raised in Seed round.
Recent news
Latest coverage and updates
- attends_eventJul 15, 2026
Epoch Biotech attended event Alzheimer's Association International Conference (AAIC) 2026 on Jul 15th '26.
- attends_eventJul 15, 2026
Epoch Biotech attended event AAIC 2026 on Jul 15th '26.
Epoch Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Epoch Biotech's valuation, stock price, and market status.
Is Epoch Biotech a public or private company?
Epoch Biotech is a private company.
What is the current stock price of Epoch Biotech?
Epoch Biotech is a private company with no public stock price. Caplight tracks Epoch Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Epoch Biotech worth (valuation)?
Valuation information for Epoch Biotech is not publicly available.
Can I buy Epoch Biotech stock?
Epoch Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Epoch Biotech's last funding round?
Epoch Biotech's most recent funding round was Grant on August 1, 2025.
Who are the main investors in Epoch Biotech?
Key investors in Epoch Biotech include National Institute on Aging.
Will Epoch Biotech IPO soon?
No public IPO plans have been announced for Epoch Biotech.
How can I track Epoch Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Epoch Biotech's secondary market activity and sign up for updates.